FDA Drug information
Dasatinib
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- Dasatinib DASATINIB 100 mg/1 Apotex Corp.
- Dasatinib DASATINIB 100 mg/1 Prasco Laboratories
- Dasatinib DASATINIB 140 mg/1 Apotex Corp.
- Dasatinib DASATINIB 140 mg/1 Prasco Laboratories
- Dasatinib DASATINIB 20 mg/1 Apotex Corp.
- Dasatinib DASATINIB 20 mg/1 Prasco Laboratories
- Dasatinib DASATINIB 50 mg/1 Apotex Corp.
- Dasatinib DASATINIB 50 mg/1 Prasco Laboratories
- Dasatinib DASATINIB 70 mg/1 Apotex Corp.
- Dasatinib DASATINIB 70 mg/1 Prasco Laboratories
- Dasatinib DASATINIB 80 mg/1 Apotex Corp.
- Dasatinib DASATINIB 80 mg/1 Prasco Laboratories
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.